Strong Industry Presence CRO Analytics operates within the specialized pharmaceutical manufacturing sector, focusing on improving clinical research efficiency, making it a key partner for biopharma companies seeking validated data and quality performance metrics.

Recent Funding Backing The company has secured Series A investments from notable funds like Ben Franklin Technology Partners, highlighting investor confidence and potential for growth and expansion within the clinical research data space.

Innovative Technology Platform With the launch of their cloud-based Performer platform and validated data collection instruments, CRO Analytics demonstrates a commitment to cutting-edge solutions that improve trial performance assessment, offering opportunities for integrated software or service collaborations.

Market Recognition and Growth Recognition as a 'Company to Watch' and active participation in strategic partnerships reflect market validation and growing adoption, indicating potential clients or partners interested in clinical trial quality improvement solutions.

Funding and Revenue Potential Generating revenue between 10 million and 25 million dollars, CRO Analytics shows significant market traction in clinical research data services, presenting ample sales opportunities with biopharma organizations and research service providers seeking enhanced performance analytics.